{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:06:59Z","timestamp":1793502419908,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-109-020"],"award-info":[{"award-number":["DMR-109-020"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-110-027"],"award-info":[{"award-number":["DMR-110-027"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nosocomial pneumonia caused by carbapenem-resistant gram-negative bacteria (CRGNB) is a growing threat due to the limited therapeutic choices and high mortality rate. The aim of this study was to evaluate the prognostic factors for mortality in patients with nosocomial pneumonia caused by CRGNB and the impact of colistin-based therapy on the outcomes of intensive care unit (ICU) patients. We conducted a retrospective study of the ICUs in five tertiary teaching hospitals in Taiwan. Patients with nosocomial pneumonia caused by CRGNB from January 2016 to December 2016 were included. Prognostic factors for mortality were analyzed using multivariate logistic regression. The influence of colistin-based therapy on mortality and clinical and microbiological outcomes were evaluated in subgroups using different severity stratification criteria. A total of 690 patients were enrolled in the study, with an in-hospital mortality of 46.1%. The most common CRGNB pathogens were <jats:italic>Acinetobacter baumannii<\/jats:italic> (78.7%) and <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (13.0%). Significant predictors (odds ratio and 95% confidence interval) of mortality from multivariate analysis were a length of hospital stay (LOS) prior to pneumonia of longer than 9\u00a0days (2.18, 1.53\u20133.10), a sequential organ failure assessment (SOFA) score of more than 7 (2.36, 1.65\u20133.37), supportive care with vasopressor therapy (3.21, 2.26\u20134.56), and escalation of antimicrobial therapy (0.71, 0.50\u20130.99). There were no significant differences between the colistin-based therapy  in the deceased and survival groups (42.1% vs. 42.7%, p\u2009=\u20090.873). In the subgroup analysis, patients with multiple organ involvement (&gt;\u20092 organs) or higher SOFA score (&gt;\u20097) receiving colistin-based therapy had better survival outcomes. Prolonged LOS prior to pneumonia onset, high SOFA score, vasopressor requirement, and timely escalation of antimicrobial therapy were predictors for mortality in critically ill patients with nosocomial CRGNB pneumonia. Colistin-based therapy was associated with better survival outcomes in subgroups of patients with a SOFA score of more than 7 and multiple organ involvement.<\/jats:p>","DOI":"10.1038\/s41598-022-11061-7","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:05:04Z","timestamp":1651917904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study"],"prefix":"10.1038","volume":"12","author":[{"given":"Chih-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-980X","authenticated-orcid":false,"given":"Kuang-Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-3749","authenticated-orcid":false,"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-8112","authenticated-orcid":false,"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Huei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Jye","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"T-CARE (Taiwan Critical Care and Infection) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Jye","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-980X","authenticated-orcid":false,"given":"Kuang-Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8840-8112","authenticated-orcid":false,"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Huei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"issue":"3","key":"11061_CR1","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres, A. et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur. Respir. J. 50(3), 1700582 (2017).","journal-title":"Eur. Respir. J."},{"issue":"12","key":"11061_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","volume":"184","author":"DR Chung","year":"2011","unstructured":"Chung, D. R. et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am. J. Respir. Crit. Care Med. 184(12), 1409\u20131417 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"11061_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s10096-016-2694-9","volume":"35","author":"D Delle Rose","year":"2016","unstructured":"Delle Rose, D. et al. Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: A retrospective analysis in six Italian hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 35(9), 1531\u20131539 (2016).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"11061_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"EV Lemos","year":"2014","unstructured":"Lemos, E. V. et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin. Microbiol. Infect. 20(5), 416\u2013423 (2014).","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"11061_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/ofid\/ofy150","volume":"5","author":"A Martin","year":"2018","unstructured":"Martin, A., Fahrbach, K., Zhao, Q. & Lodise, T. association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to enterobacteriaceae: Results of a systematic literature review and meta-analysis. Open Forum Infect. Dis. 5(7), 150 (2018).","journal-title":"Open Forum Infect. Dis."},{"key":"11061_CR6","doi-asserted-by":"publisher","first-page":"32665","DOI":"10.1038\/srep32665","volume":"6","author":"PF Wu","year":"2016","unstructured":"Wu, P. F. et al. High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. Sci. Rep. 6, 32665 (2016).","journal-title":"Sci. Rep."},{"issue":"5","key":"11061_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00134-005-2598-0","volume":"31","author":"J Garnacho-Montero","year":"2005","unstructured":"Garnacho-Montero, J. et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med. 31(5), 649\u2013655 (2005).","journal-title":"Intensive Care Med."},{"key":"11061_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40560-015-0077-4","volume":"3","author":"J Inchai","year":"2015","unstructured":"Inchai, J. et al. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J. Intensive Care. 3, 9 (2015).","journal-title":"J. Intensive Care."},{"issue":"1","key":"11061_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/dkw377","volume":"72","author":"O Zusman","year":"2017","unstructured":"Zusman, O. et al. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: Systematic review and meta-analysis. J. Antimicrob. Chemother. 72(1), 29\u201339 (2017).","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"11061_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12879-020-05026-2","volume":"20","author":"C Lyu","year":"2020","unstructured":"Lyu, C., Zhang, Y., Liu, X., Wu, J. & Zhang, J. Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis. BMC Infect. Dis. 20(1), 296 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"Suppl 7","key":"11061_CR11","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi, Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin. Infect. Dis. 69(Suppl 7), S565\u2013S575 (2019).","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"11061_CR12","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cmi.2018.01.015","volume":"24","author":"L Papst","year":"2018","unstructured":"Papst, L. et al. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin. Microbiol. Infect. 24(10), 1070\u20131076 (2018).","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"11061_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/jac\/dkaa064","volume":"75","author":"I Bellos","year":"2020","unstructured":"Bellos, I. et al. Efficacy and safety of colistin loading dose: a meta-analysis. J. Antimicrob. Chemother. 75(7), 1689\u20131698 (2020).","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"11061_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41598-020-78098-4","volume":"11","author":"W Katip","year":"2021","unstructured":"Katip, W., Yoodee, J., Uitrakul, S. & Oberdorfer, P. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae. Sci. Rep. 11(1), 18 (2021).","journal-title":"Sci. Rep."},{"issue":"12","key":"11061_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/cid\/cis286","volume":"54","author":"L Dalfino","year":"2012","unstructured":"Dalfino, L. et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin. Infect. Dis. 54(12), 1720\u20131726 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"11061_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/jcm7080208","volume":"7","author":"IL Cheng","year":"2018","unstructured":"Cheng, I. L., Chen, Y. H., Lai, C. C. & Tang, H. J. Intravenous colistin monotherapy versus combination therapy against carbapenem-resistant gram-negative bacteria infections: Meta-analysis of randomized controlled trials. J. Clin. Med. 7(8), 208 (2018).","journal-title":"J. Clin. Med."},{"issue":"9","key":"11061_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.cmi.2020.03.035","volume":"26","author":"A Nutman","year":"2020","unstructured":"Nutman, A. et al. Colistin plus meropenem for carbapenem-resistant Gram-negative infections: In vitro synergism is not associated with better clinical outcomes. Clin. Microbiol. Infect. 26(9), 1185\u20131191 (2020).","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"11061_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/CCM.0000000000000771","volume":"43","author":"A Valachis","year":"2015","unstructured":"Valachis, A., Samonis, G. & Kofteridis, D. P. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis. Crit. Care Med. 43(3), 527\u2013533 (2015).","journal-title":"Crit. Care Med."},{"key":"11061_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.01.020","author":"JY Feng","year":"2021","unstructured":"Feng, J. Y. et al. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2021.01.020 (2021).","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"11061_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijantimicag.2014.07.004","volume":"44","author":"WJ Gu","year":"2014","unstructured":"Gu, W. J., Wang, F., Tang, L., Bakker, J. & Liu, J. C. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis. Int. J. Antimicrob. Agents. 44(6), 477\u2013485 (2014).","journal-title":"Int. J. Antimicrob. Agents."},{"issue":"1","key":"11061_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13054-017-1916-6","volume":"21","author":"SY Jung","year":"2017","unstructured":"Jung, S. Y. et al. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: A systemic review and Bayesian network meta-analysis. Crit. Care. 21(1), 319 (2017).","journal-title":"Crit. Care."},{"key":"11061_CR22","unstructured":"Clinical and Laboratory Standards Institute. Document M100-S24 in Performance standards for antimicrobial susceptibility testing. Twenty-fourth international supplement (2014)."},{"key":"11061_CR23","unstructured":"Taiwan Centers for Disease Control. Nosocomial infections surveillance system. https:\/\/www.cdc.gov.tw\/Category\/MPage\/4G8HuDdUN1k4xaBJhbPzKQ (2020)."},{"issue":"4","key":"11061_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.diagmicrobio.2013.08.011","volume":"78","author":"T Kim","year":"2014","unstructured":"Kim, T. et al. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: A multicenter study in Korea. Diagn. Microbiol. Infect. Dis. 78(4), 457\u2013461 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"11061_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13756-018-0430-1","volume":"7","author":"P Yang","year":"2018","unstructured":"Yang, P. et al. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob. Resist. Infect. Control. 7, 137 (2018).","journal-title":"Antimicrob. Resist. Infect. Control."},{"issue":"2","key":"11061_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jiph.2018.10.003","volume":"12","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017. J. Infect. Public Health. 12(2), 195\u2013199 (2019).","journal-title":"J. Infect. Public Health."},{"issue":"1","key":"11061_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13756-020-00791-w","volume":"9","author":"EM Lima","year":"2020","unstructured":"Lima, E. M. et al. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: A case-case-control design in a prospective cohort study. Antimicrob. Resist. Infect. Control. 9(1), 132 (2020).","journal-title":"Antimicrob. Resist. Infect. Control."},{"issue":"4","key":"11061_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00134-013-2828-9","volume":"39","author":"M Tumbarello","year":"2013","unstructured":"Tumbarello, M. et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med. 39(4), 682\u2013692 (2013).","journal-title":"Intensive Care Med."},{"issue":"1","key":"11061_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13054-019-2627-y","volume":"23","author":"JM Cisneros","year":"2019","unstructured":"Cisneros, J. M. et al. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial. Crit. Care. 23(1), 383 (2019).","journal-title":"Crit. Care."},{"issue":"12","key":"11061_CR30","doi-asserted-by":"publisher","first-page":"1106.e1","DOI":"10.1016\/j.cmi.2015.08.001","volume":"21","author":"DR Giacobbe","year":"2015","unstructured":"Giacobbe, D. R. et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study. Clin. Microbiol. Infect. 21(12), 1106.e1-e8 (2015).","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"11061_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","volume":"22","author":"M Falcone","year":"2016","unstructured":"Falcone, M. et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin. Microbiol. Infect. 22(5), 444\u2013450 (2016).","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"11061_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","volume":"157","author":"JL Trouillet","year":"1998","unstructured":"Trouillet, J. L. et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157(2), 531\u2013539 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"11061_CR33","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1378\/chest.117.5.1434","volume":"117","author":"EH Ibrahim","year":"2000","unstructured":"Ibrahim, E. H., Ward, S., Sherman, G. & Kollef, M. H. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 117(5), 1434\u20131442 (2000).","journal-title":"Chest"},{"issue":"8","key":"11061_CR34","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12603-012-0369-5","volume":"16","author":"D Khandelwal","year":"2012","unstructured":"Khandelwal, D. et al. Frailty is associated with longer hospital stay and increased mortality in hospitalized older patients. J. Nutr. Health Aging. 16(8), 732\u2013735 (2012).","journal-title":"J. Nutr. Health Aging."},{"issue":"2","key":"11061_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1378\/chest.107.2.511","volume":"107","author":"J Almirall","year":"1995","unstructured":"Almirall, J., Mesalles, E., Klamburg, J., Parra, O. & Agudo, A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 107(2), 511\u2013516 (1995).","journal-title":"Chest"},{"key":"11061_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-7687-1","volume-title":"Encyclopedia of Machine Learning and Data Mining","author":"C Sammut","year":"2017","unstructured":"Sammut, C. & Webb, G. I. Encyclopedia of Machine Learning and Data Mining (Springer, 2017)."},{"issue":"5","key":"11061_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00134-015-3764-7","volume":"41","author":"DB Knox","year":"2015","unstructured":"Knox, D. B., Lanspa, M. J., Kuttler, K. G., Brewer, S. C. & Brown, S. M. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. 41(5), 814\u2013822 (2015).","journal-title":"Intensive Care Med."},{"issue":"20","key":"11061_CR38","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour, C. W. et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321(20), 2003\u20132017 (2019).","journal-title":"JAMA"},{"issue":"1","key":"11061_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13054-020-2778-x","volume":"24","author":"JG Wilson","year":"2020","unstructured":"Wilson, J. G. & Calfee, C. S. ARDS subphenotypes: understanding a heterogeneous syndrome. Crit Care. 24(1), 102 (2020).","journal-title":"Crit Care."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11061-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:02:57Z","timestamp":1669345377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11061-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11061-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"10 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7501"}}